Stocksigma LogoStocksigma Logo

Metropolis Healthcare Reports Strong Q2 FY27 With PAT Surging 43% YoY

Metropolis Healthcare reported robust Q2 FY27 results, with revenue rising 15.8% YoY to ₹496.8 crore and PAT surging 42.7% YoY to ₹75.5 crore

Metropolis Healthcare Reports Strong Q2 FY27 With PAT Surging 43% YoY

Metropolis Healthcare Ltd · Press Release · 04 Nov 2026, 1:13 am

Metropolis Healthcare Reports Strong Q2 FY27 With PAT Surging 43% YoY Metropolis Healthcare reported robust Q2 FY27 results, with revenue rising 15.8% YoY to ₹496.8 crore and PAT surging 42.7% YoY to ₹75.5 crore. EBITDA grew 23.9% YoY to ₹134.9 crore, with EBITDA margins expanding 180 bps to 27.2%. Volume growth remained healthy, with patient volumes up 10% YoY to 4.1 million and test volumes rising 11% YoY to 8.7 million. TruHealth and Specialty revenues each grew 20% YoY, while B2C revenue increased 17% YoY. The Board declared an interim dividend of ₹1 per share.

Original exchange filing (PDF)

More announcements from Metropolis Healthcare Ltd

All Metropolis Healthcare Ltd announcements